1. Introduction {#sec1}
===============

T2DM is a significant global health issue with potential life-threatening complications if not controlled well. Over 451 million people worldwide were estimated to live with diabetes according to the International Diabetes Federation \[[@B1]\]. T2DM continues to rise worldwide and is projected to rise to 693 million by 2045. T2DM is the most prevalent type of diabetes, accounting for around 90% of all types of diabetes. T2DM is characterized by hyperglycemia caused by impaired insulin secretion and insulin resistance. Hyperglycemia, if not controlled well, can eventually cause severe damages to various human organs, leading to serious complications, such as cardiovascular dysfunction, neuropathological damages, kidney failure, retinopathological changes, and even blindness. Although the etiology for diabetes remains unclear, both environmental and genetic factors are known to be related to the development of T2DM \[[@B2], [@B3]\]. A large number of susceptibility genes have been reported via a genome-wide association study (GWAS). Due to differences in race and region, most susceptible genes only have a weak effect on the risk of T2DM and have not been replicated by a large population.

After comprehensive investigations on T2DM, we found that peroxisome proliferator-activated receptor *γ* coactivator-1*α* (PGC-1*α*) is crucially important to T2DM. PGC-1*α* is a multifunctional regulatory factor originally identified as a coactivator of PPAR*γ* in 1998 \[[@B4]\]. PGC-1*α*, located on chromosome 4p15.1, is highly expressed in the liver and skeletal muscle and is involved in maintaining glucose, lipid, and energy homeostasis. PGC-1*α*, as a crucial gene regulatory element in various metabolic processes, has been shown to play pivotal roles in the development of obesity, insulin resistance, and T2DM \[[@B5]--[@B7]\]. In the previous studies from different countries, the association of several single-nucleotide polymorphisms (SNPs) of PGC-1*α*, such as rs8192678G\>A, rs2970847C\>T, rs3736265G\>A, and rs3755863 C\>T, with risk of T2DM were studied \[[@B8]--[@B11]\], while an A allele (mutant type) of the rs8192678 G\>A polymorphism in PGC-1*α* gene has been speculated in T2DM risk in some studies \[[@B12]--[@B14]\]; such possible link was not identified from other studies \[[@B15]\]. This discrepancy may be due to the relatively small sample size and differences among ethnicities. It is important that we can develop a meta-analysis approach to overcome limitations and disadvantages of previous studies by combining various studies and including ethnicity for reaching a conclusive validation.

In this study, the association of PGC-1*α* rs8192678 (G\>A) polymorphism and T2DM was extensively investigated more comprehensively by combining relevant studies. In addition, we combined ethnicity in all eligible studies to elucidate the explicit association of PGC-1*α* rs8192678 (G\>A) polymorphism and T2DM.

2. Methods {#sec2}
==========

2.1. Strategy of Literature Search and Database Utilization {#sec2.1}
-----------------------------------------------------------

The electronic databases, both in English and Chinese, including PubMed, Springer, Chinese National Knowledge Infrastructure, SinoMed, and Wanfang were searched for collecting relevant literatures published from January 2001 to May 2018. For all databases, we expanded broad search terms such as "PPARGC1A," "PGC-1alpha", "T2DM," "diabetic," "insulin," "hyperglycemia," "polymorphism," and "mutation" for more comprehensive information harvest. We do not set up any other filter to ensure all relevant information will be included in our investigations.

### 2.1.1. Selection Criteria {#sec2.1.1}

To ensure the comprehensiveness and integration of information retrieval, we imposed the following criteria for all relevant literatures: Studies published in peer-reviewed journalsCase-control studies referring to the association between PGC-1*α* polymorphism and T2DM riskCases and controls with allele and genotype frequenciesGenetic variants of controls that met the Hardy-Weinberg equilibrium (HWE, *P* \> 0.05).

The following studies were excluded: Studies without sufficient dataNon-case-control studiesStudies based on familyRedundant studies of duplicated data

2.2. Data Extraction {#sec2.2}
--------------------

Two researchers (Wan-ning Xia, Nan-xing Chen) independently reviewed full texts to carefully select eligible papers and extracted all information, including the first author, year of publication, ethnicity of subjects, age, gender, BMI, diagnostic criteria, sample size, molecular methods for genotype testing, and allele and genotype distribution in cases and controls. The third researcher (Wen-jia Peng) reviewed, cross-verified, and then finalized the carefully selected literature. Any disagreements were resolved by all 3 researchers through careful reexaminations altogether. If similar data were reported more than two times in different papers, only one was adopted in order to eliminate any bias. The genotype frequencies of controls in all included literatures were verified by HWE.

2.3. Quality Assessment {#sec2.3}
-----------------------

The Newcastle-Ottawa Scale (NOS) \[[@B16]\] tool was used to appraise the quality of studies by at least two researchers independently to cross-validate the result. This scale consists of three categories (Selection, Comparability, and Exposure) with eight items in total. A study can be awarded a maximum of one star for each numbered item within the Selection and Exposure categories. A maximum of two stars can be given for Comparability. Item scores range from 0 to 9 stars, and an overall score of more than 6 stars was regarded as high quality \[[@B17]\] .

2.4. Statistical Analyses {#sec2.4}
-------------------------

All statistical analyses were performed using STATA version 12.0 and RevMan v5.3 (the Cochrane Collaboration) software. The G allele is wild, and the A allele is mutated for the rs8192678 G\>A polymorphism in the PGC-1*α* gene. The pooled odds ratio (OR) with a 95% confidence interval (95% CI) was calculated in different genetic models, allelic (A vs. G), dominant (AG + AA vs. GG), recessive (AA vs. AG + GG), homozygous (AA vs. GG), and heterozygous (AG vs. GG) genetic models. Subgroup analysis by ethnicity was also conducted. Heterogeneity across studies was assessed via a chi-square test and *I*^2^. The fixed effects model was used for no heterogeneity (*I*^2^ \< 50%, *P* \> 0.05), whereas the random effects model was selected. The HWE was examined via the chi-square test. A funnel plot was used to detect potential publication bias, and the funnel plot symmetry was evaluated using Egger\'s linear regression testing on the OR. If publication bias was indicated, we further evaluated the number of missing studies by the Trim and Fill method and recalculated the pooled risk estimation with the addition of those missing studies \[[@B18]\].

3. Results {#sec3}
==========

3.1. Characteristics of the Studies {#sec3.1}
-----------------------------------

After duplicates were removed, 68 papers of potentially relevant studies were included initially. Then, 32 papers were excluded by reading abstracts carefully. Among those remaining relevant studies, 16 papers (3 studies based on family, 3 non-case-control studies, 5 studies with insufficient data, 1 duplicate data study, and 4 studies not meting HWE) were also excluded after reading the full texts ([Figure 1](#fig1){ref-type="fig"}). Thus, 20 papers consisting of 16,182 subjects (8,038 cases and 8,144 controls) were finally included in this meta-analysis. The characteristics of included studies are listed in [Table 1](#tab1){ref-type="table"}. 10 studies were undertaken in an East Asian population, 7 studies were in a Caucasian population, 2 studies were in an Indian population, and 1 study was in African people. Quality scores ranged from 4 to 8 stars with a median value of 6.48 ([Table 2](#tab2){ref-type="table"}).

3.2. Meta-analysis Results {#sec3.2}
--------------------------

For the study of the whole population included in our investigation, PGC-1*α* rs8192678 polymorphisms have shown a significant association with T2DM risk under allelic (OR: 1.24, 95% CI: 1.13-1.35), dominant (OR: 1.27, 95% CI: 1.14-1.42), recessive (OR: 1.24, 95% CI: 1.14-1.36), homozygous (OR: 1.40, 95% CI: 1.20-1.64), and heterozygous (OR: 1.20, 95% CI: 1.06-1.35) genetic models ([Table 3](#tab3){ref-type="table"}). A Fixed Effect model was only used to the recessive genetic model ([Figure 2](#fig2){ref-type="fig"}).

In a subgroup analysis, a significant association between PGC-1*α* rs8192678 polymorphisms and T2DM was only found in the East Asian population under allelic (OR: 1.15, 95% CI: 1.02-1.29), recessive (OR: 1.17, 95% CI: 1.04-1.31), and homozygous (OR: 1.31, 95% CI: 1.04-1.64) genetic models ([Table 3](#tab3){ref-type="table"}).

A significant association was observed in the Caucasian population under allelic (OR: 1.28, 95% CI: 1.09-1.49), dominant (OR: 1.37, 95% CI: 1.10-1.71), recessive (OR: 1.31, 95% CI: 1.12-1.53), homozygous (OR: 1.47, 95% CI: 1.21-1.79), and heterozygous (OR: 1.32, 95% CI: 1.05-1.66) genetic models ([Table 3](#tab3){ref-type="table"}).

This significant association was also found in the Indian population under allelic (OR: 1.35, 95% CI: 1.12-1.62), dominant (OR: 1.54, 95% CI: 1.12-2.11), recessive (OR: 1.35, 95% CI: 1.02-1.78), homozygous (OR: 1.59, 95% CI: 1.18-2.14), and heterozygous (OR: 1.52, 95% CI: 1.08-2.13) genetic models ([Table 3](#tab3){ref-type="table"}).

No AA genotype carrier was found in the African population, nor was there any significant association detected in this study.

3.3. Publication Bias {#sec3.3}
---------------------

The publication bias of these studies was assessed under a recessive genetic model by using the funnel plot ([Figure 3](#fig3){ref-type="fig"}). Egger\'s linear regression test indicated possible publication bias for the association (*T* = 3.22, *P* = 0.004) under the recessive genetic model. The Trim and Fill method was used to recalculate the pooled risk estimate. There was some indication of asymmetry (seven studies trimmed), but the results were still stable before and after this analysis ([Figure 4](#fig4){ref-type="fig"}).

3.4. Sensitivity Analysis {#sec3.4}
-------------------------

We used the leave-one-out method in the sensitivity analysis, whereas only one article was excluded each time. The removal of any one study from this meta-analysis did not change the association between PGC-1*α* rs8192678 polymorphisms and T2DM susceptibility under the recessive genetic model. This suggests that our results are stable, reliable, and robust ([Figure 5](#fig5){ref-type="fig"}).

4. Discussion {#sec4}
=============

Many epidemiological studies have investigated the genetic risk of developing T2DM using multiple single-nucleotide polymorphism- (SNP-) based GWAS approaches. However, up to today, the quantitative association of cumulative risk alleles (RAs) of such SNPs with T2DM risk has not been deterministic, limiting the potential applications of this type of research. Hence, the aim of this study was to identify deterministic genetic alteration associated with T2DM. The comprehensive meta-analysis of cross-ethnicity studies revealed T2DM risk in relation to PGC-1*α* gene rs8192678 polymorphism. We firstly report this current meta-analysis that carrying one RA in T2DM-associated SNPs can be associated with a clear risk of prevalent or incident T2DM, and we have validated our finding statistically.

In this meta-analysis, the association between PGC-1*α* gene rs8192678 polymorphism and T2DM susceptibility was detected under different genetic models. Individuals with A allele carriers can have an increased risk of T2DM, especially among the Caucasian and Indian populations. After subgroup analysis, a significant association was detected in the Caucasian population under all genetic models, and also found in the Indian population. Furthermore, people with AA genotype carriers can have a higher risk of T2DM compared to people with other genotype carriers. The association was detected in the East Asian population under recessive and homozygous genetic models. No significant association was found among the Africans because of the only one study with small sample size and without AA genotype carriers in control. Heterogeneity showed reduction after ethnicity subgroup analysis. This infers that ethnicity can be a main reason for heterogeneity. The possible publication bias, as detected by Funnel plot and Egger\'s linear regression test, suggests that further studies are still needed to validate the conclusions, while the sensitivity analysis supports that our results are stable, robust, and reliable.

Initially, Ek et al. \[[@B19]\] performed a case-control study about the relationship between PGC-1*α* rs8192678 polymorphism and T2DM. The association between PGC-1*α* polymorphism and T2DM, insulin secretion, and other related indicators was also explored in different countries, but with inconsistent and contradictory conclusions \[[@B20]--[@B23]\]. The discrepancy among original studies was common in any study of complex disease. The reasons for the discrepancy can be multifaceted, including sample size, ethnicity differences, study design, and inclusion criteria. In 2006, Barroso et al. \[[@B24]\] found a significant association between PGC-1*α* rs8192678 polymorphism and T2DM in the Caucasian population. Eight Caucasian studies from 2001 to 2005 were included in their meta-analysis, and only 2 genetic models (allelic, additive) were adopted. Because both unrelated and genealogical samples were included in their analysis, the comparability of studies might be decreased and their conclusion may be more limited, compared to the results from our study. In 2011, Yang et al. \[[@B10]\] also performed a similar meta-analysis, including studies from 2001 to 2010, and found an obvious association among Indians but not in Caucasians. However, only an allelic genetic model was adopted with subgroup analysis stratified by ethnicity. The studies included in the meta-analysis comprised family-based studies, redundantly repeated data studies, and studies that are not matched in HWE. Sharma et al. \[[@B25]\] investigated the possible association between PGC-1*α* rs8192678 polymorphism and T2DM but only included 8 studies. However, a high level of heterogeneity among these studies was identified with an *I*^2^ value of 81.58%. Hence, the reliability of the previous results has been questionable. We performed a much more comprehensive investigation, and in our meta-analysis, all included studies were detected by HWE. The selection of literature by inclusion and exclusion criteria was strictly followed to reduce the potential selection bias. We performed more comprehensively five genetic models with subgroup analysis stratified by ethnicity and literatures (after 2010). Therefore, our much more comprehensive approach offers more reliable results with new updates.

Despite our promising results, several potential limitations should also be addressed. Firstly, T2DM is a complex multifactorial disease, and we only considered the individual polymorphism without taking into account the interaction with other polymorphisms or environmental factors (dietary pattern, lifestyle, behavioral habits, etc.). Secondly, the study did not consider other relevant factors (gender, age, etc.), due to the limitation of availability of original research data. Thirdly, obesity is an important intermediate factor in the development of T2DM, but the definitions of obesity were different or not available in our included studies. It would be valuable and interesting to include obesity in the association with subgroup analysis. Finally, sample sizes were insufficient in the Indian and African populations. However, even though those factors are obviously related, none of them is indispensible in T2DM development, since T2DM can occur without any of the above factors. Therefore, despite of those limitations, a reliable conclusion can be still made from our comprehensive study.

5. Conclusion {#sec5}
=============

A significant association between PGC-1*α* rs8192678 polymorphism and T2DM susceptibility has been detected in this meta-analysis. Individuals with A allele, especially AA genotype carriers, can be more susceptible to T2DM in the Caucasian and Indian populations. Such association in East Asian and African populations needs to be further explored in larger sample studies. Further research about the interaction effect on PGC-1*α* rs8192678 polymorphism with other SNPs or environmental factors will be followed. Our finding revealed an explicit genetic variation in T2DM development. Our study provides further insight into the mechanisms by which genetic variation influences type 2 diabetes risk and glycemic traits, and it further supports that the genetic variant for type 2 diabetes risk can confer the risk diversity among different ethnicities.
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###### 

Characteristics of the included studies about the association between PGC-1*α*rs8192678 polymorphism and T2DM.

  Author                         Year   Ethnicity   T2DM   Control   Matching variables   Chi-square values of HWE   *P* value                                                 
  ------------------------------ ------ ----------- ------ --------- -------------------- -------------------------- ----------- ----- ----- ------ ------------------ ------- -------
  Chen et al. \[[@B26]\]         2004   Chinese     155    255       84                   494                        185         264   106   555    Age, gender        0.466   0.495
  De-yao et al. \[[@B27]\]       2014   Chinese     165    175       90                   430                        190         181   60    431    Age, gender        2.492   0.115
  Hui et al. \[[@B28]\]          2009   Chinese     71     28        41                   140                        47          30    11    88     Gender, BMI        1.276   0.259
  Kim et al. \[[@B14]\]          2005   Korean      251    355       152                  762                        88          163   51    303    Gender             2.779   0.096
  Lu et al. \[[@B29]\]           2006   Chinese     44     55        21                   120                        54          41    11    106    ---                0.581   0.446
  Sun et al. \[[@B30]\]          2006   Chinese     122    190       78                   390                        181         256   88    525    Age, gender, BMI   0.025   0.876
  Weng et al. \[[@B13]\]         2010   Chinese     91     129       56                   276                        340         502   207   1049   Age, gender, BMI   0.78    0.377
  Zhang et al. \[[@B31]\]        2007   Chinese     97     121       45                   263                        144         111   27    282    Age, BMI           0.679   0.41
  Zhu et al. \[[@B8]\]           2017   Chinese     138    251       108                  502                        250         382   150   784    Age, gender        0.036   0.85
  Zhu et al. \[[@B32]\]          2009   Chinese     181    303       111                  595                        143         240   112   495    Gender, BMI        0.347   0.556
  Ek et al. (a) \[[@B19]\]       2001   Caucasian   186    200       68                   454                        97          80    21    198    ---                0.541   0.462
  Ek et al. (b) \[[@B19]\]       2001   Caucasian   76     97        28                   201                        146         116   31    293    ---                1.2     0.273
  Fanelli et al. \[[@B33]\]      2005   Caucasian   51     56        18                   125                        86          96    41    223    Gender             2.431   0.126
  Jemaa et al. \[[@B34]\]        2015   Caucasian   166    231       90                   478                        176         170   56    402    Age, gender        2.055   0.152
  Kruzliak et al. \[[@B12]\]     2015   Caucasian   80     334       467                  881                        40          147   161   348    Age, gender        0.529   0.467
  Kunej et al. \[[@B35]\]        2004   Caucasian   141    129       35                   305                        114         111   15    240    Age, gender, BMI   3.156   0.076
  Lacquemant et al. \[[@B15]\]   2002   Caucasian   129    137       44                   310                        163         159   47    369    ---                0.705   0.401
  Shokouhi et al. \[[@B9]\]      2015   Caucasian   127    43        3                    173                        159         13    1     173    Age                1.531   0.216
  Bhat et al. (a) \[[@B11]\]     2007   Indian      68     103       28                   199                        112         80    21    213    BMI                1.401   0.237
  Bhat et al. (b) \[[@B11]\]     2007   Indian      69     70        13                   152                        143         96    19    258    BMI                0.269   0.604
  Sharma et al. \[[@B25]\]       2018   Indian      220    254       80                   554                        258         249   64    571    Age, sex           0.112   0.737
  Cheema et al. (a) \[[@B36]\]   2015   African     92     4         14                   110                        102         14    0     116    Gender, BMI        0.478   0.489
  Cheema et al. (b) \[[@B36]\]   2015   African     103    19        2                    124                        104         18    0     122    Gender             0.774   0.379

HWE: Hardy-Weinberg equilibrium; *P* value: *P* value of HWE.

###### 

Results of quality assessment by NOS.

  Study ID            Year   Selection   Comparability   Exposure   Score                         
  ------------------- ------ ----------- --------------- ---------- ------- ----- ----- --- ----- ---
  Bhat et al. (a)     2007   ☆           ☆               ---        ☆       ☆     ☆     ☆   ☆     7
  Bhat et al. (b)     2007   ☆           ☆               ---        ☆       ☆     ☆     ☆   ☆     7
  Cheema et al. (a)   2015   ☆           ☆               ---        ☆       ☆     ☆     ☆   ☆     7
  Cheema et al. (b)   2015   ☆           ☆               ---        ☆       ---   ☆     ☆   ☆     6
  Chen et al.         2004   ☆           ☆               ☆          ☆       ☆     ☆     ☆   ☆     8
  De-yao et al.       2014   ---         ☆               ☆          ☆       ☆     ☆     ☆   ☆     7
  Ek et al. (a)       2001   ☆           ---             ☆          ☆       ---   ☆     ☆   ☆     6
  Ek et al. (b)       2001   ☆           ---             ☆          ☆       ---   ☆     ☆   ☆     6
  Fanelli et al.      2005   ☆           ☆               ---        ☆       ---   ---   ☆   ---   4
  Hui et al.          2009   ---         ☆               ---        ☆       ☆     ☆     ☆   ☆     6
  Jemaa et al.        2015   ---         ☆               ☆          ☆       ☆     ☆     ☆   ☆     7
  Kim et al.          2005   ☆           ☆               ---        ☆       ---   ☆     ☆   ☆     6
  Kruzliak et al.     2015   ---         ☆               ☆          ☆       ☆     ☆     ☆   ☆     7
  Kunej et al.        2004   ---         ☆               ---        ---     ☆☆    ---   ☆   ☆     5
  Lacquemant et al.   2002   ---         ---             ☆          ☆       ---   ☆     ☆   ☆     5
  Lu et al.           2006   ---         ☆               ☆          ☆       ---   ☆     ☆   ---   5
  Sharma et al.       2018   ☆           ---             ☆          ☆       ☆     ☆     ☆   ---   6
  Shokouhi et al.     2015   ☆           ☆               ☆          ☆       ☆     ☆     ☆   ☆     8
  Sun et al.          2006   ---         ☆               ☆          ☆       ☆☆    ☆     ☆   ☆     8
  Weng et al.         2010   ---         ☆               ---        ☆       ☆☆    ☆     ☆   ☆     7
  Zhang et al.        2007   ---         ☆               ☆          ☆       ☆     ☆     ☆   ☆     7
  Zhu et al.          2017   ---         ☆               ---        ☆       ☆     ☆     ☆   ☆     6
  Zhu et al.          2009   ☆           ☆               ☆          ☆       ☆     ☆     ☆   ☆     8

Note: a study can be awarded a maximum of one star for each numbered item within the Selection and Exposure categories. A maximum of two stars can be given for Comparability. A maximum of 2 stars can be allotted in this category, one for age, the other for other controlled factors (gender, BMI, WHR, and so on).

###### 

Summary of meta-analysis of association between PGC-1*α*rs8192678 polymorphism and T2DM.

  Genetic model                Pooled OR (95% CI)    *Z* value   *P* value   Study number   Cases   Controls   *I* ^2^ (%)   *P* ~heterogeneity~
  ---------------------------- --------------------- ----------- ----------- -------------- ------- ---------- ------------- ---------------------
  Allelic genetic model        1.24 (1.13-1.35)      4.76        \<0.05      20             8038    8144       66.4          \<0.05
  East Asian subgroup          1.15 (1.02-1.29)      2.34        \<0.05      10             3972    4618       67.9          \<0.05
  Caucasian subgroup           1.28 (1.09-1.49)      3.07        \<0.05      7              2927    2246       65.4          \<0.05
  Indian subgroup              1.35 (1.12-1.62)      3.13        \<0.05      2              905     1042       39.8          0.19
  African subgroup             1.84 (0.90-3.74)      1.68        0.09        1              234     238        58.1          0.12
  Dominant genetic model       1.27 (1.14-1.42)      4.27        \<0.05      20             8038    8144       57.5          \<0.05
  East Asian subgroup          1.15 (1.00-1.32)      1.91        0.06        10             3972    4618       51.1          \<0.05
  Caucasian subgroup           1.37 (1.10-1.71)      2.84        \<0.05      7              2927    2246       64.8          \<0.05
  Indian subgroup              1.54 (1.12-2.11)      2.68        \<0.05      2              905     1042       61.2          0.08
  African subgroup             1.28 (0.77-2.13)      0.97        0.33        1              234     238        0             0.71
  Recessive genetic model      1.24 (1.14-1.36)      4.95        \<0.05      20             8038    8144       45.5          \<0.05
  East Asian subgroup          1.17 (1.04-1.31)      2.63        \<0.05      10             3972    4618       64.9          \<0.05
  Caucasian subgroup           1.31 (1.12-1.53)      3.45        \<0.05      7              2927    2246       0             0.52
  Indian subgroup              1.35 (1.02-1.78)      2.08        \<0.05      2              905     1042       0             0.88
  African subgroup             18.85 (2.55-139.61)   2.87        \<0.05      1              234     238        0             0.34
  Homozygous genetic model     1.40 (1.20-1.64)      4.34        \<0.05      20             8038    8144       50            \<0.05
  East Asian subgroup          1.31 (1.04-1.64)      2.3         \<0.05      10             3972    4618       64.8          \<0.05
  Caucasian subgroup           1.47 (1.21-1.79)      3.84        \<0.05      7              2927    2246       4.9           0.39
  Indian subgroup              1.59 (1.18-2.14)      3.06        \<0.05      2              905     1042       0             0.54
  African subgroup             13.63 (1.71-108.58)   2.47        \<0.05      1              234     238        0             0.36
  Heterozygous genetic model   1.20 (1.06-1.35)      2.87        0.004       20             8038    8144       59.5          \<0.05
  East Asian subgroup          1.08 (0.94-1.24)      1.07        0.29        10             3972    4618       45.4          0.06
  Caucasian subgroup           1.32 (1.05-1.66)      2.37        0.02        7              2927    2246       63.9          \<0.05
  Indian subgroup              1.52 (1.08-2.13)      2.40        0.02        2              905     1042       62.9          0.07
  African subgroup             0.63 (0.20-2.07)      0.76        0.45        1              234     238        68.3          0.08

A, mutant type; genetic model: allelic (A vs. G), dominant (AG + AA vs. GG), recessive (AA vs. AG + GG), homozygous (AA vs. GG), and heterozygous (AG vs. GG).

[^1]: Academic Editor: Roberta Rizzo
